Triple9 Wednesday, 09/27/17 11:56:45 AM Re: None Post # of 340 $SGMO is pre-clinical with 3 current Phase 1/2 studies with data due by March 2018. But the pipeline is very wide and this will be an interesting stock in the 3-5 year time frame. Congrats to everyone who got aboard this train in the $5 range!!! http://www.sangamo.com/product-pipeline Know What You Own. My posts should not be construed as investment advice.